Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Tomislav Kostić, Marina Deljanin Ilić, Zoran Perišić, Dragan Milić, Miodrag Đorđević, Mladjan Golubović, Goran Koraćević, Sonja Šalinger Martinović, Snežana Ćirić Zdravković, Saša Živić, Milan Lazarević, Dragana Stanojević, Sonja Dakić, Jelena Lilić & Aleksandar Veselinović. (2020) Design and development of novel therapeutics for coronary heart disease treatment based on cholesteryl ester transfer protein inhibition – in silico approach. Journal of Biomolecular Structure and Dynamics 38:8, pages 2304-2313.
Read now
Read now
Junteng Zhou, Qi Zhang, Yushu Wang, Peijuan Gao & Decai Chen. (2018) The effect and safety of anacetrapib in the treatment of dyslipidemia: a systematic review and meta-analysis. Postgraduate Medicine 130:1, pages 129-136.
Read now
Read now
Sebastian Filippas-Ntekouan, Theodosios D. Filippatos & Moses S. Elisaf. (2018) SGLT2 inhibitors: are they safe?. Postgraduate Medicine 130:1, pages 72-82.
Read now
Read now
T. D. Filippatos, M. Florentin, M. Georgoula & M. S. Elisaf. (2017) Pharmacological management of diabetic dyslipidemia. Expert Review of Clinical Pharmacology 10:2, pages 187-200.
Read now
Read now
Articles from other publishers (19)
Calum A. MacRaeRandall T. Peterson. (2023) Zebrafish as a Mainstream Model for In Vivo Systems Pharmacology and Toxicology. Annual Review of Pharmacology and Toxicology 63:1, pages 43-64.
Crossref
Crossref
Kei Nakajima, Manami Igata, Ryoko Higuchi, Kotone Tanaka, Kaori Mizusawa & Teiji Nakamura. (2021) Association of Serum High-Density Lipoprotein Cholesterol with High Blood Pressures at Checkup: Results of Kanagawa Investigation of Total Checkup Data from the National Database-9 (KITCHEN-9). Journal of Clinical Medicine 10:21, pages 5118.
Crossref
Crossref
Mingying Wang, Yuantao Zhou, Xiaoli He, Chengjun Deng, Xiaoning Liu, Juan Li, Lin Zhou, Ying Li, Yu Zhang, Haifeng Liu & Li Li. (2021) Two novel mutations of the LPL gene in two Chinese family cases with familial chylomicronemia syndrome. Clinica Chimica Acta 521, pages 264-271.
Crossref
Crossref
Xiaoni Zhang, Haidong Xia, Jie Wang, Ruyue Leng, Xiaojing Zhou, Qian Gao, Kan He, Dahai Liu & Bei Huang. (2021) Effect of selenium-enriched kiwifruit on body fat reduction and liver protection in hyperlipidaemic mice. Food & Function 12:5, pages 2044-2057.
Crossref
Crossref
Eleni Pappa, Moses S. Elisaf, Christina Kostara, Eleni Bairaktari & Vasilis K. Tsimihodimos. (2020) Cardioprotective Properties of HDL: Structural and Functional Considerations. Current Medicinal Chemistry 27:18, pages 2964-2978.
Crossref
Crossref
Chao Chen, Renhua Sun, Yan Sun, Xuan Chen, Fei Li, Xiaoan Wen, Haoliang Yuan & Dongyin Chen. (2020) Synthesis, biological evaluation and SAR studies of ursolic acid 3β-ester derivatives as novel CETP inhibitors. Bioorganic & Medicinal Chemistry Letters 30:2, pages 126824.
Crossref
Crossref
Annelieke C. Kruithof, Rajinder Kumar, Jasper Stevens, Marieke L. Kam, Anirudh Gautam, Shanavas Alikunju, Bijay K. Padhi, Swati Kulkarni, Rajeev S. Raghuvanshi, Rajesh Gandhi, Jacobus Burggraaf & Ingrid M.C. Kamerling. (2019) Effect of Food on the Pharmacokinetics of 2 Formulations of DRL‐17822, a Novel Selective Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Males. Clinical Pharmacology in Drug Development 8:8, pages 1042-1052.
Crossref
Crossref
Theodosios D. Filippatos, Angelos Liontos, Eliza C. Christopoulou & Moses S. Elisaf. (2019) Novel Hypolipidaemic Drugs: Mechanisms of Action and Main Metabolic Effects. Current Vascular Pharmacology 17:4, pages 332-340.
Crossref
Crossref
Jeferson L. da Silva, Raul C. Maranhão, Michelle S.M. Silva, Rodrigo G. Dias, Fatima R. Freitas, Wladimir Bolani, José R. Lemos Junior, Cleber R. Alves, Patrícia A. Oliveira, Guilherme B. Alves, Edilamar M. Oliveira, Carlos Eduardo Negrao, José Eduardo Krieger, Alexandre C. Pereira, Gisele A. Silva, José P. Souza & Carmen G.C. Vinagre. (2019)
Aerobic Training in Young Men Increases the Transfer of Cholesterol to High Density Lipoprotein
In Vitro
: Impact of High Density Lipoprotein Size
. Lipids 54:6-7, pages 381-388.
Crossref
Crossref
W. Masson, M. Lobo, D. Siniawski, M. Huerín, G. Molinero, R. Valéro & J.P. Nogueira. (2018) Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk. Diabetes & Metabolism 44:6, pages 508-513.
Crossref
Crossref
Maria Mytilinaiou, Ioannis Kyrou, Mike Khan, Dimitris K. Grammatopoulos & Harpal S. Randeva. (2018) Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management. Frontiers in Pharmacology 9.
Crossref
Crossref
Theodosios D. Filippatos, Thalia Panagiotopoulou, Eleftheria Tzavella & Moses S. Elisaf. (2018) Hypolipidemic Drugs and Diabetes Mellitus—Mechanisms and Data From Genetic Trials. Journal of Cardiovascular Pharmacology and Therapeutics 23:3, pages 187-191.
Crossref
Crossref
Theodosios D. Filippatos, Anastazia Kei, Christos V. Rizos & Moses S. Elisaf. (2017) Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables. Journal of Cardiovascular Pharmacology and Therapeutics 23:1, pages 3-12.
Crossref
Crossref
Tao Chen, Meng Sun, Jia-Qiang Wang, Jin-Jin Cui, Zhong-Hua Liu & Bo Yu. (2017) A novel swine model for evaluation of dyslipidemia and atherosclerosis induced by human CETP overexpression. Lipids in Health and Disease 16:1.
Crossref
Crossref
Theodosios D. Filippatos, Anastazia Kei & Moses S. Elisaf. (2017) Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?. Diseases 5:4, pages 21.
Crossref
Crossref
Amanda L. Brown & J. Mark Brown. (2017) Anacetrapib-driven triglyceride lowering explained: the fortuitous role of CETP in the intravascular catabolism of triglyceride-rich lipoproteins. Journal of Lipid Research 58:6, pages 1031-1032.
Crossref
Crossref
Massimo Volpe, Roberto Volpe, Giovanna Gallo, Vivianne Presta, Giuliano Tocci, Emanuela Folco, Andrea Peracino, Elena Tremoli & Bruno Trimarco. (2017) 2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document. High Blood Pressure & Cardiovascular Prevention.
Crossref
Crossref
Shoucui Gao, Xiaojing Wang, Daxing Cheng, Jiayan Li, Lu Li, Linwu Ran, Sihai Zhao, Jianglin Fan & Enqi Liu. (2017) Overexpression of Cholesteryl Ester Transfer Protein Increases Macrophage-Derived Foam Cell Accumulation in Atherosclerotic Lesions of Transgenic Rabbits. Mediators of Inflammation 2017, pages 1-9.
Crossref
Crossref
Sangeeta Kashyap, Karim Kheniser, Ling Li, James Bena & Takhar Kasumov. (2016) The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes. Lipids in Health and Disease 15:1.
Crossref
Crossref